MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-01-24 (cfo.com)
CFOs On the Move: Week ending Jan. 24 |
Abnormal Security names a new finance chief as it preps for an IPO, Birkenstock appoints a new CFO and Medtronic hires its new CFO from Renault.
Read more
2024-10-22 (investing.com)
Medtronic shareholders elect board of directors, approve executive compensation By Investing.com
Medtronic shareholders elect board of directors, approve executive compensation
Read more
2024-10-22 (investing.com)
Medtronic shareholders elect board, approve executive pay By Investing.com
Medtronic shareholders elect board, approve executive pay
Read more
2022-01-07 (valuewalk.com)
SVN Capital Fund 2021 Annual Letter: Dino Polska SA
SVN Capital Fund’s portfolio returned +23.60% gross and +21.09% net of all fees (subject to audit) for the year 2021.
Read more